To address these observations, we are currently in the process of determining as to whether the advanced age-dependent increase of central nervous system IDO expression directly increases the peripheral Treg/CD8+ cytolytic T cell ratio and how this relationship affects the incidence and mortality rate, as well as responsiveness to immunotherapy of GBM. This evidence concerns the gene IDO1 and glioblastoma.